Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
gene therapy
life sciences
national blog main
national top stories
new york top stories
san francisco top stories
spinal muscular atrophy
zolgensma
2
×
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
arch venture partners
billy dunn
biogen
boston blog main
boston top stories
boxer capital
clinical trials
deals
dravet syndrome
drug prices
drug pricing
ed kaye
encoded therapeutics
europe top stories
evrysdi
fda
genentech
generation bio
hemophilia
illumina
illumina ventures
ionis pharmaceuticals
matrix capital management
menlo ventures
national
new york blog main
novartis
What
medicine
2
×
therapy
approved
atrophy
crude
cutting
daily
despite
drug
edge
effects
encoded
evrysdi
fda
friday
gene
green
help
home
illumina’s
intended
lasting
lights
limited
limits
liquid
long
muscular
nabs
new
oral
patients
progress
promising
push
remains
risdiplam
roche
single
spinal
Language
unset
Current search:
zolgensma
×
medicine
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
